Contattaci Contact Us

12 October 2021 - Day 1

  • Speaker Francesco Lanza

    Session date 12/10/2021 - 08:30

  • Speaker Brunangelo Falini

    Session date 12/10/2021 - 08:40

  • DNA repair inhibitors: a possible role in myeloid malignancies

    Speaker Damiano Rondelli

    Session date 12/10/2021 - 09:00

  • Mechanism of resistance

    Speaker Giovanni Martinelli

    Session date 12/10/2021 - 09:20

  • General Discussion Session I

    Speaker -

    Session date 12/10/2021 - 09:40

  • Secondary AML

    Speaker Arnon Nagler

    Session date 12/10/2021 - 10:20

  • Induction and Consolidation Therapy of high risk Leukemia

    Speaker Felicetto Ferrara

    Session date 12/10/2021 - 10:40

  • Allogeneic SCT for High Risk leukemia: when and how

    Speaker Emanuele Angelucci

    Session date 12/10/2021 - 11:00

  • General Discussion Session II

    Speaker -

    Session date 12/10/2021 - 11:20

  • Targeting Apoptosis in AML - venetoclax

    Speaker Dietger Niederwisier

    Session date 12/10/2021 - 13:00

  • Midostaurine and new FLT3 inhibitors

    Speaker Giovanni Marconi

    Session date 12/10/2021 - 13:20

  • IDH1 and IDH2 inhibitors

    Speaker Jorge Cortés

    Session date 12/10/2021 - 13:40

  • Car-T

    Speaker Bipin Savani

    Session date 12/10/2021 - 14:00

  • Strategy to overcome resistance of emerging agents

    Speaker Tapan M. Kadia

    Session date 12/10/2021 - 14:20

  • Targeting MDM2 as a new treatment approach in AML

    Speaker Tapan M. Kadia

    Session date 12/10/2021 - 15:00

  • Bispecific antibody construct for the treatment of AML

    Speaker Marion Subklewe

    Session date 12/10/2021 - 15:40

  • Hedgehog inhibitors

    Speaker Adriano Venditti

    Session date 12/10/2021 - 16:00

  • Immune based approaches in AML

    Speaker Naval Daver

    Session date 12/10/2021 - 16:20

  • General Discussion Session IV

    Speaker -

    Session date 12/10/2021 - 16:40

  • Clinical impact of MRD monitoring

    Speaker Nigel Russell

    Session date 12/10/2021 - 17:20

  • Flow cytometry monitoring

    Speaker Francesco Buccisano

    Session date 12/10/2021 - 17:40

  • MRD by NGS

    Speaker Peter J. M. Valk

    Session date 12/10/2021 - 18:00

  • General Discussion Session V

    Speaker -

    Session date 12/10/2021 - 18:40

13 October 2021 - Day 2

  • Mast cell leukemia

    Speaker Michela Rondoni

    Session date 13/10/2021 - 09:00

  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN)

    Speaker Livio Pagano

    Session date 13/10/2021 - 09:20

  • General Discussion Session VI

    Speaker -

    Session date 13/10/2021 - 09:40

  • High-end GENome-editing platform to deliver next generation allogeneic iPSC-derived CAR-NK and T immunotherapy “GENiCAR”

    Speaker Alejandro Madrigal

    Session date 13/10/2021 - 10:00

  • Intersecting genomic medicine and system pharmacology for profiling therapeutic sensitivity in leukemia

    Speaker Giovanni Roti

    Session date 13/10/2021 - 10:20

  • Haploidentical transplantation in AML

    Speaker Marcos J. De Lima

    Session date 13/10/2021 - 10:40

  • General Discussion Session VII

    Speaker -

    Session date 13/10/2021 - 11:00

  • Ph+ leukemia: biology and resistance

    Speaker Simona Soverini

    Session date 13/10/2021 - 11:40

  • Treatment of Ph+ALL in young and elderly

    Speaker Alessandro Rambaldi

    Session date 13/10/2021 - 12:00

  • Transplant in Ph+

    Speaker Sebastian Giebel

    Session date 13/10/2021 - 12:20

  • General Discussion Session VIII

    Speaker -

    Session date 13/10/2021 - 12:40

  • Transplant in Ph-

    Speaker Alexandros Spdyridonidis

    Session date 13/10/2021 - 14:00

  • First line therapy and overall approach

    Speaker Elias J. Jabbour

    Session date 13/10/2021 - 14:20

  • Role of immunotherapy in refractory-resistant ALL

    Speaker Francesco Lanza

    Session date 13/10/2021 - 14:40

  • Ph Like leukemia

    Speaker Ilaria Iacobucci

    Session date 13/10/2021 - 15:00

  • General Discussion Session IX

    Speaker -

    Session date 13/10/2021 - 15:20

  • Conclusion of the Symposium

    Speaker Francesco Lanza

    Session date 13/10/2021 - 15:40

Reserved area

APP FONDAZIONE MENARINI



Pills of Art Menarini

“Pills of Art”
A new multimedia project dedicated to the art world.



New Projects: MINUTI DIGITALE



Minuti Menarini Online

Subscribe for free to the paper version of the magazine



Fondazione Menarini



SIGN UP FOR THE NEWSLETTER

Receive information about the Fondazione Menarini every month.

VGFM DATA-LAYER

Fondazione Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484